Non Serious Adverse Drug Reactions Report

Start Date:2016-04-19 End Date:2016-04-20
Study :EMR700623-541Investigator :NACountry of Investigator :ChinaSiteNo:C02
Subject No :C02-0002Subject Initials :LLLDOB :02/12/1987Sex:FemaleRace:AsianHeight:158cmWeight:50.0kg
First administration date of batch :Batch number :
Study DrugStart DateDoseChange in Dose
Gonal-f New Pen Stimulation Treatment05/08/2015150
Adverse EventStart DateEnd DateTime related to study treatmentCausality to study drugSeverity
OHSS05/25/201506/03/2015RelatedModerate
Causality FactorsAction Taken with Study TreatmentOther action takenOutcomeAE Special InterestAE dose limiting toxicity
None(Othervalue:)Not applicableLed to study terminationResolved
Event Description:Moderate OHSS patients, improved canceled after embryo transfer.
Subject received concomitant medications:
Does the subject have any relevant past or present medical conditions:Yes
ConditionStart DateRelated to study conditionOngoing
salpingemphrxis,lalace peritoneoscopeUk-Jul-2014Not on treatment/medication



19-APR-16
NA/EMR700623-541/C02-0002
Page 1 of56
 

Non Serious Adverse Drug Reactions Report

Start Date:2016-04-19 End Date:2016-04-20
Study :EMR700623-541Investigator :NACountry of Investigator :ChinaSiteNo:C02
Subject No :C02-0034Subject Initials :L-ZDOB :09/04/1981Sex:FemaleRace:AsianHeight:156cmWeight:53.0kg
First administration date of batch :Batch number :
Study DrugStart DateDoseChange in Dose
Gonal-f New Pen Stimulation Treatment05/13/2015150
Adverse EventStart DateEnd DateTime related to study treatmentCausality to study drugSeverity
OHSS05/30/201506/05/2015RelatedModerate
Causality FactorsAction Taken with Study TreatmentOther action takenOutcomeAE Special InterestAE dose limiting toxicity
None(Othervalue:)Not applicableLed to study terminationResolved
Event Description:Moderate OHSS occurs canceled embryo transfer, OHSS improvement
Subject received concomitant medications:
Does the subject have any relevant past or present medical conditions:No
ConditionStart DateRelated to study conditionOngoing



19-APR-16
NA/EMR700623-541/C02-0034
Page 2 of56
 

Non Serious Adverse Drug Reactions Report

Start Date:2016-04-19 End Date:2016-04-20
Study :EMR700623-541Investigator :NACountry of Investigator :ChinaSiteNo:C02
Subject No :C02-0043Subject Initials :F-HDOB :03/13/1983Sex:FemaleRace:AsianHeight:164cmWeight:54.0kg
First administration date of batch :Batch number :
Study DrugStart DateDoseChange in Dose
Gonal-f New Pen Stimulation Treatment05/13/2015225
Adverse EventStart DateEnd DateTime related to study treatmentCausality to study drugSeverity
OHSS05/30/201506/05/2015RelatedModerate
Causality FactorsAction Taken with Study TreatmentOther action takenOutcomeAE Special InterestAE dose limiting toxicity
None(Othervalue:)Not applicableLed to study terminationResolved
Event Description:Moderate OHSS patients, improved canceled after embryo transfer.
Subject received concomitant medications:
Does the subject have any relevant past or present medical conditions:Yes
ConditionStart DateRelated to study conditionOngoing
Laparoscopic tubal ectopic pregnancy at the right side of the window to take embryoUk-Unk-2005Not on treatment/medication
Under the right fallopian tube ectopic pregnancy laparoscopic surgeryUk-Unk-2007Not on treatment/medication



19-APR-16
NA/EMR700623-541/C02-0043
Page 3 of56
 

Non Serious Adverse Drug Reactions Report

Start Date:2016-04-19 End Date:2016-04-20
Study :EMR700623-541Investigator :NACountry of Investigator :ChinaSiteNo:C02
Subject No :C02-0045Subject Initials :H-TDOB :09/08/1983Sex:FemaleRace:AsianHeight:158cmWeight:57.5kg
First administration date of batch :Batch number :
Study DrugStart DateDoseChange in Dose
Gonal-f New Pen Stimulation Treatment05/13/2015250
Adverse EventStart DateEnd DateTime related to study treatmentCausality to study drugSeverity
OHSS 05/28/201506/05/2015RelatedModerate
Causality FactorsAction Taken with Study TreatmentOther action takenOutcomeAE Special InterestAE dose limiting toxicity
None(Othervalue:)Not applicableLed to study terminationResolved
Event description:Moderate OHSS occurs canceled embryo transfer, OHSS improvement
Subject received concomitant medications:
Does the subject have any relevant past or present medical conditions:Yes
ConditionStart DateRelated to study conditionOngoing
Hysteroscopic polypectomyUk-Aug-2014Not on treatment/medication
 



19-APR-16
NA/EMR700623-541/C02-0045
Page 4 of 56
 

Non Serious Adverse Drug Reactions Report

Start Date:2016-04-19 End Date:2016-04-20
Study :EMR700623-541Investigator :NACountry of Investigator :ChinaSiteNo:C02
Subject No :C02-0046Subject Initials :Q-HDOB :10/07/1985Sex:FemaleRace:AsianHeight:161cmWeight:50.0kg
First administration date of batch :Batch number :
Study DrugStart DateDoseChange in Dose
Gonal-f New Pen Stimulation Treatment05/13/2015150
Adverse EventStart DateEnd DateTime related to study treatmentCausality to study drugSeverity
OHSS05/28/201506/05/2015RelatedModerate
Causality FactorsAction Taken with Study TreatmentOther action takenOutcomeAE Special InterestAE dose limiting toxicity
None(Othervalue:)Not applicableLed to study terminationResolved
Event Description:Moderate OHSS patients, improved canceled after embryo transfer.
Subject received concomitant medications:
Does the subject have any relevant past or present medical conditions:No
ConditionStart DateRelated to study conditionOngoing



19-APR-16
NA/EMR700623-541/C02-0046
Page 5 of56